Come up with a name for your new list and we'll add to it:
Imgenex was acquired by
Novus Biologicals on October 31, 2013.
Imgenex develops and commercializes reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These reage…